World News: 22:07 GMT Wednesday 16th May 2018. [G1 Therapeutics via Globe Newswire via SPi World News]
RESEARCH TRIANGLE PARK NC May 16 2018 GLOBE NEWSWIRE) -- G1 Therapeutics Inc NasdaqGTHX a clinical-stage oncology company today announced that preliminary data from its Phase 1b2a clinical trial of G1T38 in combination with Faslodex (fulves...
Globe Newswire: 22:07 GMT Wednesday 16th May 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.